Many developing countries pursue a biotechnology based catch-up strategy in the hope of closing their technological gap with industrialized countries. Their strategies, however, are not similar, since biotechnology, which is a generic technology, encompasses several independent yet interrelated branches. Some countries have chosen to focus on just one branch, with the intention of becoming a
... [Show full abstract] specialized niche for the globalized market (on the case of stem cell research in Singapore, see Chaturvedi 2005); others have designed a comprehensive plan encompassing more or less all the branches. Iran as a member of the second group is a relatively vast country with a large variety of flora and fauna, biological reserves, and a population of roughly 76 million, which includes 3.8 million students in higher education.